The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Racial diversity and reporting in FDA registration trials for thoracic malignancies from 2006 to 2020.
 
Ryan S. Chiang
No Relationships to Disclose
 
Michael Glover
No Relationships to Disclose
 
Gavin Hui
No Relationships to Disclose
 
Aakash Desai
No Relationships to Disclose
 
Heather A. Wakelee
Consulting or Advisory Role - AstraZeneca; Blueprint Medicines; Daiichi Sankyo; Helsinn Therapeutics; Janssen Oncology; Mirati Therapeutics; Xcovery
Research Funding - ACEA Biosciences (Inst); Arrys Therapeutics (Inst); AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Clovis Oncology (Inst); Exelixis (Inst); Genentech/Roche (Inst); Gilead Sciences (Inst); Merck (Inst); Novartis (Inst); Pharmacyclics (Inst); Seagen (Inst); Xcovery (Inst)
(OPTIONAL) Uncompensated Relationships - Genentech/Roche; Merck; Takeda
 
Mark Lythgoe
No Relationships to Disclose
 
Ali Raza Khaki
Stock and Other Ownership Interests - Merck; Sanofi